查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1647935

氣喘監測設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按設備、按最終用戶、按地區和競爭細分，2020-2030 年

Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球氣喘監測設備市場價值為 2.8513 億美元，預計到 2030 年將達到 4.0586 億美元，預測期內複合年成長率為 6.26%。全球氣喘監測設備市場正在經歷持續成長，這得益於氣喘盛行率的上升、氣喘管理意識的增強以及醫療技術的不斷進步。氣喘是一種以呼吸道發炎和狹窄為特徵的慢性呼吸系統疾病，影響著全球數百萬人。監測設備在評估肺功能、追蹤症狀和管理治療以減少發作和提高生活品質方面發揮著至關重要的作用。根據世界衛生組織 (WHO) 的數據，全球有近 5 億人患有氣喘和慢性阻塞性肺病 (COPD)，這兩種疾病每年導致近 400 萬人死亡，其中超過 100 萬人死於70歲以下的個人。令人震驚的是，90% 的過早死亡發生在中低收入國家 (LMIC)。政府和醫療保健組織正在積極推動更好的氣喘管理，從而促進監測設備的普及。對早期檢測和預防的公眾教育進一步鼓勵了人們持續使用這些設備。然而，先進的氣喘監測設備成本高昂，可能會讓一些患者難以承受，特別是在低收入地區，這限制了其廣泛應用。此外，雖然城市人口擴大使用這些設備，但農村地區仍然面臨認知度和可近性方面的挑戰，阻礙了市場滲透。

市場概況
預測期 2026-2030
2024 年市場規模 2.8513億美元
2030 年市場規模 4.0586億美元
2025-2030 年複合年成長率 6.26%
成長最快的領域 智慧吸入器
最大的市場 北美洲

2024 年 10 月，FDA 和疾病管制與預防中心 (CDC) 在《發病率和死亡率週報》中發布了 2024 年全國青少年菸草調查 (NYTS) 有關青少年菸草使用的調查結果。資料顯示，225萬名國中和高中學生報告稱，在過去30天裡，他們有一天或多天使用過至少一種菸草產品。發展中國家醫療保健基礎設施的擴展和人們對氣喘管理的認知的不斷提高為市場提供了巨大的成長機會。新興市場城市化進程的加速可能會推動對氣喘監測解決方案的需求。此外，監測設備與遠距醫療平台的整合使醫療保健提供者能夠遠端追蹤和調整患者的治療，尤其是在偏遠地區。預計未來幾年這一趨勢將會成長。儘管高成本和區域接入差異等挑戰依然存在，但新興市場的機會以及遠距醫療的整合為市場持續成長提供了途徑。透過專注於創新和提高患者參與度，氣喘監測設備市場可望快速發展，為全球氣喘患者提供更有效的解決方案。

主要市場促進因素

哮喘盛行率上升

遠端患者監控日益受到重視

提高認知和教育

主要市場挑戰

有限報銷政策

互通性問題

主要市場趨勢

遠距醫療和遠端監控

關注兒童氣喘監測

分段洞察

設備洞察

最終使用者見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備（肺量計、智慧吸入器、峰值流量計）
    • 按最終使用者（醫院和診所、家庭護理、診斷實驗室）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
  • 按設備
  • 按最終用戶
  • 按地區

第 6 章：北美氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備
    • 按最終用戶
    • 按國家
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備
    • 按最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備
    • 按最終用戶
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備
    • 按最終用戶
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲氣喘監測設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按設備
    • 按最終用戶
    • 按國家
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：全球氣喘監測設備市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips NV
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

第 16 章：策略建議

第17章 關於出版商,免責事項

簡介目錄
Product Code: 20032

Global Asthma Monitoring Device Market was valued at USD 285.13 Million in 2024 and is expected to reach USD 405.86 Million by 2030 with a CAGR of 6.26% during the forecast period. The global asthma monitoring device market is experiencing consistent growth driven by the increasing prevalence of asthma, heightened awareness of asthma management, and continuous advancements in medical technologies. Asthma, a chronic respiratory condition marked by airway inflammation and narrowing, affects millions of individuals globally. Monitoring devices play a vital role in evaluating lung function, tracking symptoms, and managing treatment to reduce flare-ups and enhance quality of life. According to the World Health Organization (WHO), nearly half a billion people live with asthma and chronic obstructive pulmonary disease (COPD), and these two conditions are responsible for almost 4 million deaths annually, with over 1 million of those deaths occurring prematurely in individuals under 70 years old. Alarmingly, 90% of premature deaths occur in low- and middle-income countries (LMICs). Governments and healthcare organizations are actively promoting better asthma management, leading to greater adoption of monitoring devices. Public education on early detection and prevention further encourages consistent use of these devices. However, the high cost of advanced asthma monitoring equipment may be prohibitive for some patients, particularly in lower-income regions, limiting their widespread adoption. Additionally, while urban populations increasingly use these devices, rural areas continue to face challenges with awareness and accessibility, impeding market penetration.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 285.13 Million
Market Size 2030USD 405.86 Million
CAGR 2025-20306.26%
Fastest Growing SegmentSmart Inhalers
Largest MarketNorth America

In October 2024, the FDA and the Centers for Disease Control and Prevention (CDC) published findings from the 2024 National Youth Tobacco Survey (NYTS) regarding youth tobacco use in the Morbidity and Mortality Weekly Report. The data revealed that 2.25 million middle and high school students reported using at least one tobacco product on one or more days in the past 30 days. The expansion of healthcare infrastructure and growing awareness about asthma management in developing countries offer significant growth opportunities for the market. The rising urbanization in emerging markets is likely to drive the demand for asthma monitoring solutions. Moreover, the integration of monitoring devices with telemedicine platforms enables healthcare providers to remotely track and adjust treatments for patients, especially in remote areas. This trend is expected to grow in the coming years. Although challenges such as high costs and regional access disparities remain, opportunities in emerging markets, along with the integration of telemedicine, offer avenues for continued market growth. With a focus on innovation and improved patient engagement, the asthma monitoring device market is poised to evolve rapidly, providing more effective solutions for asthma patients around the world.

Key Market Drivers

Rising Prevalence of Asthma

The growing global prevalence of asthma is expected to significantly drive the expansion of the Global Asthma Monitoring Device Market. According to the GINA 2024 Report, asthma is one of the most common chronic non-communicable diseases, affecting over 300 million people and causing around 1,000 deaths daily worldwide, many of which are preventable. As asthma incidence continues to rise, the demand for effective and efficient monitoring solutions to manage and control the condition is also increasing. This heightened demand is expected to spur innovation and attract investment in asthma monitoring devices, further fueling market growth. Asthma monitoring devices play a crucial role in enabling individuals to track and manage their respiratory health, providing real-time data and insights to both patients and healthcare professionals. As patient awareness of the importance of proactive asthma management grows, the adoption of these monitoring devices is expected to increase, supporting market growth. Additionally, advancements in technology such as the integration of smart features and wireless connectivity are improving user experience and enabling remote monitoring, which will further drive the market's expansion. In Ireland, for example, the Asthma Society of Ireland reports that 890,000 people will experience asthma at some point in their lives, with 380,000 individuals currently affected. One in 13 people and one in 10 children in Ireland are living with asthma. The rising asthma prevalence, combined with the growing emphasis on personalized healthcare and the adoption of innovative technologies, positions the asthma monitoring device market for substantial growth in the near future.

Growing Emphasis on Remote Patient Monitoring

The burgeoning emphasis on Remote Patient Monitoring (RPM) is poised to be a key catalyst in propelling the growth of the Global Asthma Monitoring Device Market. With a paradigm shift towards decentralized healthcare, the demand for Asthma Monitoring Devices is escalating due to their integral role in facilitating remote tracking of patients' respiratory health. As healthcare systems increasingly prioritize preventive care and patient-centric approaches, these monitoring devices offer a crucial solution for continuous, real-time assessment without the necessity of frequent in-person visits. The integration of Asthma Monitoring Devices with wireless connectivity and smart technologies enables seamless data transmission to healthcare professionals, fostering timely intervention and personalized care plans. This not only empowers patients to actively manage their condition but also allows healthcare providers to make informed decisions remotely, improving overall patient outcomes. The growing adoption of telehealth practices and the need for efficient chronic disease management, especially in the context of asthma, positions the Asthma Monitoring Device Market at the forefront of technological innovation and remote healthcare delivery. This trend is anticipated to drive sustained market growth as the healthcare landscape continues to evolve towards patient-centric, technology-enabled solutions.

Increasing Awareness and Education

The growth of the Global Asthma Monitoring Device Market is set to be significantly driven by a rise in awareness and education around respiratory health. As awareness campaigns and educational efforts gain momentum, more individuals are recognizing the importance of effectively monitoring and managing asthma. For example, Philips' awareness campaign educates consumers on asthma and helps people better manage their symptoms. This growing awareness is leading to a heightened demand for asthma monitoring devices, as people adopt a more proactive and informed approach to respiratory care.

Education on the benefits of continuous asthma monitoring, as well as the role these devices play in early detection and management, is key to encouraging their widespread adoption. Patients are increasingly seeking these devices as part of their regular healthcare routines. Additionally, CIPLA, India's third-largest pharmaceutical company, has launched a campaign (#InhalersHainSahi) to raise awareness about asthma and emphasize the vital role inhalers play in managing the condition. As asthma continues to be a global health challenge, improving awareness and preparedness is critical to effectively combating the disease.

Investing in asthma prevention efforts, including health education and innovative strategies, is essential to raising community awareness and promoting preventative practices. These educational initiatives are also beneficial for healthcare professionals, who are now better equipped to recommend and incorporate asthma monitoring devices into personalized care plans, further driving market growth. The convergence of technology and healthcare education is particularly impactful, as informed consumers are more inclined to embrace innovative solutions. As a result, the Global Asthma Monitoring Device Market is poised to benefit significantly from this increasing awareness, expanding its market base as more individuals take a proactive approach to managing their respiratory health.

Key Market Challenges

Limited Reimbursement Policies

Limited reimbursement policies pose a significant obstacle to the growth of the Global Asthma Monitoring Device Market. The financial landscape of healthcare is a crucial determinant of consumer adoption and healthcare provider recommendation of monitoring devices. When reimbursement policies are restrictive or inadequately cover the costs associated with Asthma Monitoring Devices, both patients and healthcare institutions may be deterred from investing in these technologies. Healthcare providers often rely on reimbursement support to justify the integration of new technologies into patient care. Limited coverage for asthma monitoring devices may result in decreased willingness to prescribe or recommend these devices, hindering their market penetration. This, in turn, affects patient access and adoption rates, especially among those who depend on insurance coverage for medical expenses. For patients, out-of-pocket costs can be a significant barrier to acquiring these devices, leading to suboptimal management of asthma. The market's growth is inherently linked to the alignment of reimbursement policies with the value proposition of asthma monitoring devices, and addressing these limitations is pivotal for fostering widespread adoption and ensuring the sustained growth of the Asthma Monitoring Device Market on a global scale.

Interoperability Issues

Interoperability issues present a formidable barrier to the growth of the Global Asthma Monitoring Device Market. The seamless exchange of data between various healthcare systems, electronic health records (EHRs), and monitoring devices is crucial for the effective management of chronic conditions like asthma. However, disparate standards and a lack of standardized protocols for data communication hinder the smooth integration of asthma monitoring devices into existing healthcare ecosystems. When interoperability is compromised, healthcare providers face challenges in accessing and utilizing the data generated by these devices, leading to fragmented patient care. The inability of asthma monitoring devices to seamlessly communicate with other health information systems not only impedes efficient care coordination but also diminishes the overall value proposition of these devices. Moreover, interoperability issues may contribute to increased implementation costs for healthcare institutions, as they may need to invest in additional infrastructure or customized solutions to overcome compatibility challenges. This, in turn, can slow down the adoption rate of asthma monitoring devices on a broader scale. To foster the growth of the Asthma Monitoring Device Market, addressing interoperability challenges is imperative. Standardizing communication protocols and promoting interoperable solutions will enhance the utility of these devices, driving their integration into comprehensive healthcare strategies and ultimately benefiting both healthcare providers and patients.

Key Market Trends

Telehealth and Remote Monitoring

The Global Asthma Monitoring Device Market is set to experience accelerated growth due to the rising prominence of telehealth and remote monitoring solutions. According to data from the US Centers for Disease Control (CDC), published in the American Journal of Managed Care, asthma is estimated to cost USD 80 billion annually. Telehealth, combined with asthma monitoring devices, presents a transformative approach to managing respiratory health. The convenience and accessibility of remote monitoring empower patients to actively engage in their care, facilitating early interventions and tailored treatment plans.

By integrating asthma monitoring devices with telehealth platforms, real-time data can be transmitted to healthcare providers, enabling proactive decision-making without the need for in-person visits. This not only boosts patient engagement but also streamlines healthcare delivery, particularly in remote or underserved areas. The global shift toward telehealth, fueled by technological advancements and the growing demand for virtual healthcare options, creates a favorable environment for the widespread adoption of asthma monitoring devices.

For example, in February 2024, Singapore-based respiratory monitoring device company Aevice Health partnered with London-based Jiva.ai to develop a remote patient monitoring platform that enables individuals with asthma to track their condition and predict asthma attacks. This collaboration, partly funded by the UK government's Innovate UK business grant scheme and Singapore's Enterprise Singapore, leverages the FDA-approved AeviceMD, a wearable smart stethoscope that continuously monitors asthma biomarkers. This system allows patients to monitor their condition from home while providing healthcare providers with valuable insights to optimize care. As telehealth becomes a core element of modern healthcare systems, the integration of telehealth with asthma monitoring devices is poised to drive market growth by delivering efficient, patient-centered solutions that align with the evolving healthcare landscape.

Focus on Pediatric Asthma Monitoring

The Global Asthma Monitoring Device Market is poised for substantial growth with an increasing focus on pediatric asthma monitoring. Recognizing the unique needs and challenges of managing asthma in children, there is a growing demand for specialized monitoring devices tailored to the pediatric population. This emphasis on pediatric asthma care is driven by a heightened awareness of the prevalence of childhood asthma and the importance of early intervention. Pediatric asthma monitoring devices offer features specifically designed to address the developmental and behavioral aspects of children, making it easier for parents and healthcare providers to manage the condition effectively. The integration of child-friendly designs, user-friendly interfaces, and interactive features enhances compliance and engagement, ensuring accurate and consistent monitoring. Moreover, the rising incidence of pediatric asthma, coupled with a proactive approach towards preventive healthcare, positions the market for pediatric asthma monitoring devices as a critical component in the overall asthma management landscape. As healthcare providers and parents prioritize the well-being of children with asthma, the market is expected to witness sustained growth by catering to the specific needs of this demographic, ultimately contributing to improved health outcomes for pediatric asthma patients globally.

Segmental Insights

Device Insights

Based on Device, the Smart Inhalers emerged as the fastest growing segment in the global market for Asthma Monitoring Device during the forecast period. The Global Asthma Monitoring Device Market is set to experience robust growth driven by the integration of Smart Inhalers. These innovative devices represent a paradigm shift in asthma management, combining traditional inhalers with digital technology to provide real-time data and insights. Smart Inhalers not only ensure accurate medication delivery but also offer features such as dose reminders, inhalation technique feedback, and wireless connectivity. The smart features of these inhalers empower patients to actively engage in their asthma management by tracking medication usage and monitoring respiratory patterns. This data is then seamlessly transmitted to healthcare providers, enabling personalized treatment plans and timely interventions. The enhanced connectivity of Smart Inhalers aligns with the broader trends in digital health and telemedicine, facilitating remote patient monitoring and improving overall healthcare outcomes. As the demand for more efficient and patient-centric healthcare solutions grows, the market for Smart Inhalers is expected to expand significantly. The convergence of respiratory care with smart technology not only addresses the evolving needs of asthma patients but also positions the Global Asthma Monitoring Device Market at the forefront of innovation in chronic disease management.

End-User Insights

Based on End-User, the Hospitals & Clinics emerged as the dominating segment in the global market for Asthma Monitoring Device in 2024. Hospitals and clinics are poised to be key drivers of growth in the Global Asthma Monitoring Device Market. As healthcare institutions increasingly prioritize comprehensive and patient-centric care, the integration of asthma monitoring devices becomes imperative for optimizing respiratory health management. Hospitals and clinics, acting as pivotal points in the healthcare delivery system, are instrumental in shaping the adoption and utilization of these devices. The demand for asthma monitoring devices is expected to surge in healthcare settings, driven by the need for more efficient and proactive approaches to respiratory care. These devices offer healthcare providers valuable real-time data, facilitating informed decision-making and personalized treatment plans. The integration of asthma monitoring devices aligns with the broader trend of digital transformation in healthcare, enhancing the quality of patient care and streamlining clinical workflows. Moreover, the rising prevalence of asthma and the emphasis on preventive healthcare further underscore the significance of monitoring devices in hospitals and clinics. As these institutions prioritize the implementation of advanced technologies to improve patient outcomes, the Global Asthma Monitoring Device Market stands to benefit significantly from increased adoption within the healthcare sector.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Asthma Monitoring Device Market in 2024. The North America region is poised to be a major catalyst for driving the growth of the Global Asthma Monitoring Device Market. Several factors contribute to this, including a robust healthcare infrastructure, a high prevalence of asthma cases, and a strong emphasis on technological innovation in healthcare. In North America, particularly in the United States and Canada, there is a heightened awareness of respiratory health, and a growing number of individuals are seeking advanced solutions for asthma management. The region's well-established healthcare ecosystem, characterized by a network of hospitals, clinics, and research institutions, facilitates the integration and adoption of asthma monitoring devices. Furthermore, the region's affinity for cutting-edge healthcare technologies, coupled with a favorable regulatory environment, encourages the development and deployment of innovative asthma monitoring solutions. The presence of key market players and research and development activities in North America further propels market growth. As healthcare stakeholders increasingly prioritize preventive care and patient engagement, the demand for asthma monitoring devices is expected to escalate in North America. The region's influential role in shaping healthcare trends positions it as a driving force behind the expansion of the Global Asthma Monitoring Device Market.

Key Market Players

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

Report Scope:

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Monitoring Device Market, By Product:

  • Spirometer
  • Smart Inhalers
  • Peak Flow Meter

Asthma Monitoring Device Market, By End-User:

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Laboratories

Asthma Monitoring Device Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Monitoring Device Market.

Available Customizations:

Global Asthma Monitoring Device market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Monitoring Device Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 5.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Device
  • 5.3.2 By End-User
  • 5.3.3 By Region

6. North America Asthma Monitoring Device Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 6.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Monitoring Device Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Asthma Monitoring Device Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Asthma Monitoring Device Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By End-User

7. Europe Asthma Monitoring Device Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 7.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Asthma Monitoring Device Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By End-User
    • 7.3.2. Germany Asthma Monitoring Device Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Asthma Monitoring Device Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Asthma Monitoring Device Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Asthma Monitoring Device Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By End-User

8. Asia Pacific Asthma Monitoring Device Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 8.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Monitoring Device Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Asthma Monitoring Device Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Asthma Monitoring Device Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Asthma Monitoring Device Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Asthma Monitoring Device Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By End-User

9. South America Asthma Monitoring Device Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 9.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Asthma Monitoring Device Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Asthma Monitoring Device Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Asthma Monitoring Device Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Asthma Monitoring Device Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 10.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Asthma Monitoring Device Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Asthma Monitoring Device Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Asthma Monitoring Device Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Asthma Monitoring Device Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COSMED srl.
    • 15.1.1. Business Overview
    • 15.1.2. Product Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. Teleflex Incorporated.
  • 15.3. SCHILLER.
  • 15.4. Hill-Rom, Inc.
  • 15.5. Koninklijke Philips N.V.
  • 15.6. ICU Medical, Inc.
  • 15.7. SDI Diagnostics
  • 15.8. AstraZeneca plc.
  • 15.9. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer